These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1673466)

  • 1. Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1.
    Lucey DR; McGuire SA; Clerici M; Hall K; Benton J; Butzin CA; Ward WW; Shearer G; Boswell RN; Hendrix CW
    J Infect Dis; 1991 May; 163(5):971-5. PubMed ID: 1673466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune status.
    Lucey DR; McGuire SA; Abbadessa S; Hall K; Woolford B; Valtier S; Butzin CA; Melcher GP; Hendrix CW
    Viral Immunol; 1993; 6(4):267-72. PubMed ID: 7909441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF follow-up in HIV-1 infection: intrathecal production of HIV-specific and unspecific IGG, and beta-2-microglobulin increase with duration of HIV-1 infection.
    Elovaara I; Nykyri E; Poutiainen E; Hokkanen L; Raininko R; Suni J
    Acta Neurol Scand; 1993 May; 87(5):388-96. PubMed ID: 8333244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early markers of HIV infection and subclinical disease progression.
    Dolan MJ; Lucey DR; Hendrix CW; Melcher GP; Spencer GA; Boswell RN
    Vaccine; 1993; 11(5):548-51. PubMed ID: 8098175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.
    Yilmaz A; Fuchs D; Hagberg L; Nillroth U; Ståhle L; Svensson JO; Gisslén M
    BMC Infect Dis; 2006 Mar; 6():63. PubMed ID: 16566834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
    Royal W; Selnes OA; Concha M; Nance-Sproson TE; McArthur JC
    Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid analysis in human immunodeficiency virus infection.
    Hall CD; Snyder CR; Robertson KR; Messenheimer JA; Wilkins JW; Robertson WT; Whaley RA; Van der Horst C; Silverman LM
    Ann Clin Lab Sci; 1992; 22(3):139-43. PubMed ID: 1354427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.
    McArthur JC; Nance-Sproson TE; Griffin DE; Hoover D; Selnes OA; Miller EN; Margolick JB; Cohen BA; Farzadegan H; Saah A
    Neurology; 1992 Sep; 42(9):1707-12. PubMed ID: 1355286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1.
    Singer EJ; Syndulko K; Fahy-Chandon BN; Shapshak P; Resnick L; Schmid P; Conrad AJ; Tourtellotte WW
    AIDS; 1994 Feb; 8(2):197-204. PubMed ID: 7913815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunovirological study of central nervous system involvement during HIV-1 infection of chimpanzees.
    Grimaldi LM; Murthy KK; Martino G; Furlan R; Franciotta D; Eichberg JW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):12-7. PubMed ID: 8797680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.
    Gisslén M; Chiodi F; Fuchs D; Norkrans G; Svennerholm B; Wachter H; Hagberg L
    Scand J Infect Dis; 1994; 26(5):523-33. PubMed ID: 7855550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus.
    Gulevich SJ; McCutchan JA; Thal LJ; Kirson D; Durand D; Wallace M; Mehta P; Heyes MP; Grant I
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):1002-7. PubMed ID: 8101873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.
    Mulder JW; Krijnen P; Coutinho RA; Bakker M; Goudsmit J; Lange JM
    Genitourin Med; 1991 Jun; 67(3):188-93. PubMed ID: 1906425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal synthesis of beta 2-microglobulin and lysozyme: differential markers of nervous system involvement in patients infected with human immunodeficiency virus type 1.
    Meillet D; Bélec L; Celton N; Gervais A; Reboul J; Gentilini M; Delattre J; Schuller E
    Eur J Clin Chem Clin Biochem; 1993 Oct; 31(10):609-15. PubMed ID: 8292660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.
    Enting RH; Prins JM; Jurriaans S; Brinkman K; Portegies P; Lange JM
    Clin Infect Dis; 2001 Apr; 32(7):1095-9. PubMed ID: 11264039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease.
    Singer EJ; Syndulko K; Fahy-Chandon B; Schmid P; Conrad A; Tourtellotte WW
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):265-71. PubMed ID: 7906304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine.
    Jacobson MA; Abrams DI; Volberding PA; Bacchetti P; Wilber J; Chaisson RE; Crowe S; Howard W; Moss A
    J Infect Dis; 1989 Jun; 159(6):1029-36. PubMed ID: 2566637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
    Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
    JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.